The timing of your GLP-1 dose matters when fasting
What does this post say about body weight extremes and ovulation
The Problem With GLP-1 Agonists Among the most concerning claims are reports of gastroparesis, a debilitating condition characterized by stomach paralysis, which can lead to chronic nausea, vomiting, diarrhea, bowel blockages, dangerous malnutrition, and other health issues
The global l-carnitine supplements market is estimated to be valued at USD 242.7 million in 2025
How GLP-1 Use Can Impact Fueling for Active People An important takeaway from our conversation is that many athletes already have a hard time eating adequately to match their activity levels, so adding a GLP-1 medication to the mix can present a major problem
The dual agonism explains why tirzepatide produces approximately 5-7 percentage points more weight loss than GLP-1-only agents